Control of Atherosclerosis Regression by PRMT2 in Diabetes.

机译：控制pRmT2在糖尿病中的动脉粥样硬化抑制。

获取原文

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Garabedian, M.;
展开▼
作者单位

展开▼
年度 2017
页码 1-8
总页数 8
原文格式 PDF
正文语种 eng
中图分类
关键词
Sclerosis; Diabetes; Heart diseases; Enzymes; Macrophages; Substrates; Glucose; Atherosclerosis regression; Prmt2 enzyme; Lxr transcriptional activity; Atherosclerotic plaques;

机译：硬化;糖尿病;心脏病;酶;巨噬细胞;底物;葡萄糖;动脉粥样硬化消退; prmt2酶; Lxr转录活性;动脉粥样硬化斑块;

相似文献

外文文献
中文文献
专利

1. A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial. [J] . Bertrand OF, Poirier P, Rodes Cabau J The Canadian journal of cardiology . 2009,第9期

机译：一项多中心，随机，双盲安慰剂对照试验，评估罗格列酮对2型糖尿病患者冠状动脉搭桥术后动脉粥样硬化进展的预防作用。旁路手术（VICTORY）试验后静脉静脉粥样硬化和罗格列酮的设计和原理。
2. Arginine Methylation by PRMT2 Controls the Functions of the Actin Nucleator Cobl [J] . Hou Wenya, Nemitz Sabine, Schopper Simone, Developmental cell . 2018,第2期

机译：PRMT2的精氨酸甲基化控制肌动蛋白核心COBL的功能
3. Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes. [J] . Altinova AE, Toruner F, Akturk M, Scandinavian journal of clinical and laboratory investigation. . 2011,第4期

机译：2型糖尿病患者血清骨保护素，血糖控制，肾功能与动脉粥样硬化标志物之间的关系。
4. Atherosclerosis and Angiotensin Ii in Hypercholesterolemia and Diabetes. A Role For Ai Receptors Beyond Hypertension [C] . William B. Strawn, Dvm, Phd, International Society for Heart Research.Congress . 2003

机译：动脉粥样硬化和血管紧张素II在高胆固醇血症和糖尿病中。 AI 受体之外的AI 受体的作用
5. Long-chain acyl -CoA synthesis at the crossroads between glucose and fatty acid-enhanced inflammation and atherosclerosis in diabetes. [D] . Kanter, Jenny E. 2010

机译：葡萄糖和脂肪酸增强炎症和动脉粥样硬化之间的交汇处的长链酰基辅酶A合成。
6. A multicentre randomized double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial [O] . Olivier F Bertrand, Paul Poirier, Josep Rodés-Cabau, 2009

机译：一项多中心随机双盲安慰剂对照试验评估罗格列酮对2型糖尿病患者冠状动脉搭桥术后动脉粥样硬化进展的预防作用。旁路手术（VICTORY）试验后静脉静脉粥样硬化和罗格列酮的设计和原理
7. A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial [O] . Bertrand, Olivier F, Poirier, Paul, Rodés-Cabau, Josep, 2009

机译：一项多中心，随机，双盲安慰剂对照试验，评估罗格列酮对2型糖尿病患者冠状动脉搭桥术后动脉粥样硬化进展的预防作用。旁路手术（VICTORY）试验后静脉静脉粥样硬化和罗格列酮的设计和原理
8. Control of Atherosclerosis Regression by PRMT2 in Diabetes. [R] . Fisher, E. 2017

机译：控制pRmT2在糖尿病中的动脉粥样硬化抑制。

Control of Atherosclerosis Regression by PRMT2 in Diabetes.

著录项

引文网络

相似文献

相关主题

期刊订阅